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Newborns have a higher gastrointestinal uptake of cadmium than adults. In adults, the iron transporters DMT1 and FPN1 are
involved in the intestinal absorption of cadmium, while in neonates, the mechanisms for cadmium absorption are unknown. We
have investigated possible cadmium transporters in the neonatal intestine by applying a model of immature human intestinal
epithelial Caco-2 cells. To mimic the continuous cadmium exposure via diet in neonates, cells were allowed to differentiate for
7 days in medium containing 1 𝜇M CdCl
2
. A dramatic upregulation of the MT1 gene expression followed cadmium pretreatment,
indicating a high sensitivity of the immature cells to cadmium. Cadmium pretreatment increased the basolateral efflux of 109Cd,
without causing any effects on the passive diffusion of mannitol or the transepithelial electrical resistance.The augmented transport
of cadmiumwas correlated to an upregulation ofMRP1 gene expression and increased activity of the efflux proteinMRP1. No effects
were observed on gene expression of the efflux proteins MRP2 and P-gp or the iron transporters DMT1, DMT1-IRE and FPN1. In
conclusion, our data indicate that continuous cadmium exposure increases the absorption of the metal in immature intestinal cells
and that MRP1 is involved in the intestinal cadmium absorption in newborns.
1. Introduction
Cadmium is a ubiquitous toxic metal that has no known
biological functions but causes several adverse health effects
in humans. Neonates are more sensitive to cadmium toxicity
than adults, due to a higher gastrointestinal absorption [1–
3] and the potential of the element to interfere in the
development of the central nervous system [4]. The main
source for cadmium exposure in infants is cereal and soy-
based infant formulas and weaning foods [3].
The intestinal absorption of cadmium in adults is gener-
ally low but increases during iron deficiency [5–9], suggesting
that dietary cadmium is absorbed in the intestine by the
same mechanism as non-heme iron. The major transporters
responsible for the absorption of nonheme iron are the
apical influx divalent metal transporter 1 (DMT1) and the
basolateral efflux ferroportin 1 (FPN1) [10–12]. DMT1, the
isoform DMT1-IRE (containing an iron responsive element)
and FPN1 expressions are induced in human adults during
iron deficiency and repressed under iron sufficient conditions
[13, 14]. In addition, studies in adult rats have demonstrated
a strong correlation between cadmium absorption and duo-
denal expressions of DMT1 and FPN1 [15, 16]. However, in
newborns the possible role of DMT1 and FPN1 in cadmium
absorption has not been clarified. It has been demonstrated
that the expression and localization of DMT1 and FPN1 in
duodenal enterocytes is not affected by iron status, neither in
suckling piglets at postnatal day 16 nor in suckling rat pups
at postnatal day 10, indicating an immature regulation of iron
[17, 18]. Thus, cadmium absorption seems to be regulated by
other mechanisms at this developmental stage.
Gastrointestinal cadmium absorption may also be medi-
ated by proteins belonging to the ATP binding cassette
(ABC) superfamily of transporters [19]. Multidrug resistance
associated protein 1 (MRP1) is a transporter involved in the
basolateral efflux of compounds out of enterocytes into the
systemic circulation [20]. Cadmium upregulates MRP1 and
the protein have been demonstrated to mediate transport
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of the metal in functional yeast experiments [21, 22]. The
efflux proteins MRP2 and P-glycoprotein (P-gp) located at
the apical membrane of enterocytes are also upregulated by
cadmium [23, 24] and may thus influence the bioavailability
of the metal.
Repeated cadmium treatment has previously been shown
to increase cadmium absorption compared to a single treat-
ment both in vivo and in intestinal in vitro preparations of
adult rats [25]. However, even though MT involvement has
been suggested, the cellular mechanism for how cadmium
enhances its own absorption remains to be elucidated [25].
Intestinal MT is induced by cadmium [26], but there are
numerous reports concluding that the impact of MT on the
intestinal cadmium absorption is of minor importance [27].
It appears that the predominant role of this cytosolic small
molecular weight metal binding protein is to protect the cells
from cytotoxic effects [28].
Twenty-one-day postconfluent Caco-2 cells, which are
fully differentiated (mature), have been extensively used as
an in vitro model of the adult human intestinal epithelium
[29]. Under normal cell culture conditions, Caco-2 cells
spontaneously differentiate into a phenotype that resembles
polarized absorptive enterocytes [30–32]. The Caco-2 model
has been widely used to investigate cadmium absorption and
effects [33–38]. Mature Caco-2 cells treated with iron have
reduced uptake and transport of cadmium that correlates to
iron-induced decrease in DMT1 levels [37]. In concordance,
a reduced cadmium uptake was demonstrated in Caco-2 cells
subjected to molecular DMT1 knock down [33]. The ABC
efflux transporters MRP1, MRP2, and P-gp are present in
Caco-2 cells [39, 40] and the expression of P-gp in these
cells has been shown to be induced by long-term cadmium
treatment [23].
The present study was undertaken to investigate possible
transporters involved in the absorption of cadmium in the
neonatal intestine and the impact of cadmium pretreatment.
To mimic the continuous cadmium exposure in neonates via
milk and/or formula, confluent Caco-2 cells were allowed to
differentiate during 7 days (referred to as “immature Caco-
2 cells”) in the presence and absence of cadmium. Apical to
basolateral transport, studies with cadmium were performed
and gene expressions of the transporters MRP1, MRP2, P-gp,
DMT1, DMT1-IRE, FPN1, and of MT were quantified as well
as the MRP1 activity.
2. Materials and Methods
2.1. Chemicals. Cadmium chloride and nitrilotriacetic acid
were purchased from Sigma Aldrich. Dulbeccos’ modi-
fied Eagle medium (DMEM), heat inactivated fetal calf
serum, nonessential amino acids for modified Eagle medium
(MEM), N-2-hydroxyethyl-piperazine-N󸀠-2-ethanesulfonic
acid (HEPES) buffer 1M, nonessential amino acids (100x),
and gentamycin were purchased from Invitrogen via VWR
International, LLC. Apo-transferrin (tissue culture grade)
was obtained from Calbiochem via VWR International,
LLC. [14C]-mannitol (specific activity 2.09GBq/mmol) was
purchased from PerkinElmer and 109Cd (specific activity
15.2 GBq/mg Cd2+) from GE Healthcare. Ultima Gold (scin-
tillation liquid) was obtained from Chemical Instruments
AB. Calcein acetoxymethyl ester (calcein AM) fluorescent
dye was purchased from BD Biosciences. Hank’s balanced
salt solution (HBSS) and all other chemicals used, but not
specified in the experiments, were of analytical grade and
from VWR International, LLC.
2.2. Cell Culture and Treatment. Human intestinal Caco-2
cells were obtained from American Cell Culture Collection
(Rockville, USA). The cells were cultured as previously
described [41] with some minor modifications. Briefly, the
Caco-2 cells were expanded in normal tissue culture flasks in
DMEM supplemented with 10% fetal calf serum (Invitrogen)
and 1% gentamycin (50mg/mL, Invitrogen). The cells were
seeded onto permeable polycarbonate filters at a density of
2.5 × 105 cells/filter support (Ø 12mm, pore radius 0.4𝜇m,
Transwell, Corning), and apical medium was changed 8 h
after seeding to remove excess of cells and to reduce the risk of
multilayer formation [42].TheCaco-2 cells were then allowed
to differentiate for 7 days postconfluency. The medium was
changed every second day, and the cells were examined daily
by reverse phase microscopy for confluence, shape of cells,
and dome formations. Cells of passage numbers 97–100 were
used in the experiments.
Each cell monolayer was randomly assigned to differen-
tiate for 7 days postconfluency in control (C) medium or
medium supplemented with 1 𝜇M cadmium (CdCl
2
× 1H
2
O)
(Cd). Previous investigations have demonstrated that the
viability of the Caco-2 cells at various stages of differentiation
is not affected by 1 𝜇M cadmium treatment [26].
2.3. Assessment of Monolayer Integrity. The integrity of the
control and cadmium pretreated monolayers was exam-
ined by determining the permeability of the hydrophilic
marker 14C-mannitol, mainly as described [42]. Briefly, cell
monolayers were rinsed with prewarmed Hank’s Balanced
Salt Solution pH 7.4 (HBSS) and then incubated in HBSS
at 37∘C for 20min. The HBSS was discarded from the
apical chambers prior to transferring the filters to a fresh
and prewarmed plate containing 1.5mL 37∘C HBSS in the
basolateral chambers. HBSS (0.5mL, pH 6.3) prewarmed to
37∘C and containing 0.14 𝜇Ci/mL 14C-mannitol was added to
the apical chambers. The transport experiment was carried
out at 37∘C under gentle shaking (50 rpm) for 3 h. Every
30min the filters with the monolayers were transferred to
new wells containing 37∘C HBSS and samples from both the
apical and basolateral chambers were taken for subsequent
determination of radioactivity by 𝛽-spectrometry (Tricarb
1900CA, Packard). The integrity of the monolayers was
also verified by measuring the net transepithelial electrical
resistance (TEER) across the monolayers, as described [42].
Resistance across monolayers was measured in control and
cadmium supplemented media (pH 7.4, 37∘C), and back-
ground resistance was measured across filters without cells.
2.4. 109Cd Transport and Uptake. Cell monolayers, differ-
entiated for 7 days postconfluency in control medium or
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Table 1: Primer sequences used for quantitative real-time PCR.
Primer Oligo sequence NCBI GenBank Accession No. Product size (bp)
MRP1 forward 5󸀠-GCAAATCCAGGAGACAGCTC-3󸀠 NM 004996 113
MRP1 reverse 5󸀠-TGATGTGCCTGAGAACGAAG-3󸀠
MRP2 forward 5󸀠-CTGGTTGGGAACCTGACTGT-3󸀠 NM 000392 172
MRP2 reverse 5󸀠-CAACAGCCACAATGTTGGTC-3󸀠
P-gp forward 5󸀠-GCTGTTAAGGAAGCCAATGC-3󸀠 NM 000927 120
P-gp reverse 5󸀠-AGCAATGGCGATTCTCTGTT-3󸀠
DMT1 forward 5󸀠-CGTGGCGGATTGCAGGAGGA-3󸀠 NM 001174126 124
DMT1 reverse 5󸀠-ACGCTGACCACAGCAGCCAC-3󸀠
DMT1-IRE forward 5󸀠-GCCATCAGAGCCAGTGTGTTTCT-3󸀠 NM 001174125 198
DMT1-IRE reverse 5󸀠-TGTCAGCTTTTCAAAGATCCCACC-3󸀠
FPN1 forward 5󸀠-CGAGATGGATGGGTCTCCTA-3󸀠 NM 014585 219
FPN1 reverse 5󸀠-GGCTACGTCGAAAATGTGGT-3󸀠
MT1 forward 5󸀠-GCAAATGCAAAGAGTGCAAA-3󸀠 NM 005946 213
MT1 reverse 5󸀠-ATGGGTCAGGGTTGTATGGA-3󸀠
medium supplemented with cadmium were used for uptake
(from apical chamber into the cells) and transport (from
apical chamber via the cells into the basolateral chamber)
experiments. The experiments were performed at 37∘C, pH
7.4, in sterile filtered HBSS, buffered with 25mM HEPES,
mainly as previously described [41]. Briefly, the monolayers
were first rinsed in prewarmed HBSS and then incubated in
HBSS at 37∘C for 20min before being transferred to newwells
where fresh, 37∘C HBSS was added to the apical (0.5mL, pH
6.3) and basolateral (1.5mL, pH 7.4, supplementedwith 15𝜇M
human apo-transferrin) chambers. The apical solution was
supplemented with 30 nM 109Cd (1𝜇Ci/mL). To determine
the transport of 109Cd across the monolayers 1.4mL, samples
were taken from the basolateral chambers at 30min intervals
for 3 h and at the same time the cell monolayers were
transferred to new wells containing prewarmed HBSS as
described above. The radioactivity in the collected sam-
ples was measured by 𝛾-spectrometry (Cobra, Auto-gamma,
Packard). To determine the cellular uptake of 109Cd from
the apical chamber following the 3 h incubation period, the
filters with the monolayers were rinsed in 4∘C HBSS for
5min and then dissolved in 1mL 0.5M NaOH for 48 h,
followed by 𝛾-spectrometry of an aliquote of the lysate. In
order to reduce the unstirred water layer during the transport
and uptake experiments, a plate shaker was used to agitate
the monolayers at a rate of 50 rpm. The experiments were
reproduced two times.
2.5. Quantitative Gene Expression. Total RNA from Caco-
2 cells treated as described above prior to the transport
experiments was isolated by the use of NucleoSpin RNA
II kit containing Dnase I, according to the instructions
of the manufacturer (Macherey-Nagel, Germany). The cells
were rinsed with ice cold PBS prior to the addition of
lysis buffer and the isolation of RNA. The integrity of the
RNA was confirmed by gel electrophoresis, and quantifi-
cation of the RNA was performed according to the RNA-
specificQuant-iTRiboGreen protocol (Invitrogen). RNAwas
stored at −70∘C until used for quantitative gene expression
analyses.
Quantification of gene expressions of the proteins pre-
sented in Table 1 was performed by one step real-time
RT-PCR by applying a Rotorgene, RG 3000 instrument
(Corbett Research, Australia) and QuantiTect SYBR Green
RT-PCR (Qiagen) reagents, mainly according to the manu-
facturer’s instructions. Gene expression was normalized to
total RNA. Primer concentration was 0.4 𝜇M, and 200 ng
total RNAwas used as template. Gene-specific primers for the
human genes were designed by using NCBI primer design,
and all gene products were sequenced and compared against
the human genome by applying the UCSC Human Genome
Browser (Table 1). Triplicate 25𝜇L volume RT-PCR reactions
were used under the following PCR cycling conditions. Step
1: 50∘C 30min; Step 2: 95∘C 15min; Step 3: 94∘C 60 sec;
Step 4: 55∘C 60 sec; Step 5: 68∘C 45 s; Step 6: 35 or 40
repeats of steps 3–5; Step 7: 68∘C 7min. In the analyses, five
known concentrations of the human genes and a nontemplate
control served as internal controls. Melt curve analysis was
performed for each sample to check the specificity of the
obtained PCR products. Relative quantification of mRNA
expressions was performed as previously described [43].
Quantification of gene expressions as well as analyses of melt
curves were carried out by the use of Rotorgene Software
(Corbett Research, Australia).
2.6. Functional Activity: MRP-Mediated Efflux of Calcein. To
measure the functional activity of MRP transporter proteins
following cadmium pretreatment, an efflux assay with calcein
was performed. Calcein AM is a lipophilic, nonfluorescent
dye that rapidly enters cells through the plasma membrane.
Once inside the cell, endogenous esterases cleave the AM
ester bond releasing calcein, a hydrophilic, highly fluores-
cent dye that becomes trapped inside the cell. The ABC
transporters MRP1 and MRP2 have been shown to transport
both calcein AM and calcein. In contrast, P-gp transporter
proteins efflux the nonfluorescent calcein AM, but not the
fluorescent calcein from the cells into the apical chamber
[44]. MRP1 transport proteins efflux both the nonfluorescent
calcein AM and the fluorescent calcein from the cells across
the basolateral membrane, andMRP2 transports both calcein
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AMand calcein although across the apicalmembrane into the
apical chamber [45].
Cells were seeded onto filters and allowed to differentiate
in medium supplemented with Cd as described above. The
monolayers were washed as described above in 37∘C HBSS,
buffered with 25mM HEPES before loading the cells with
1.3 𝜇Mcalcein AM solved in 1%DMSO and added both to the
apical and basolateral chambers.The loading of the cells with
the permeable calcein AM was conducted at 7∘C, to reduce
the active efflux by P-gp and MRPs of the compound, for 1 h
in HBSS. Two quick washes in 7∘C HBSS were performed
after loading to remove excessive calcein AM and then the
monolayers were transferred to new wells with 37∘C HBSS,
starting the efflux study. During the 2 h efflux study, samples
were withdrawn every 30min from the basolateral chambers.
At the end of the experiment, samples were withdrawn also
from the apical chambers. The samples were immediately
transferred to black 96 plate wells and fluorescence was
measured instantly at 490 nm (excitation) and at 520 nm
(emission) by a multiplate reader. During the loading and
efflux experiment, a plate shaker was used to gently agitate
the monolayers at a rate of 50 rpm as described above.
The functional assay of MRP-mediated calcein efflux was
reproduced two times.
2.7. Statistical Analyses. The data are presented as mean
± SEM, unless otherwise stated. The apparent perme-
ability coefficient for mannitol was calculated as 𝑃app =
(dQ/dt)(1/(AC
0
)), where dQ/dt is the steady state flux
(dpm/s), 𝐴 is the filter area (cm2), and 𝐶
0
is the initial
concentration in the apical chamber (𝜇M). The statistical
software Minitab release 15 (Minitab Inc.) was used for
calculations of basic descriptive statistics and analysis of
variances (ANOVA). Data were tested for homogeneity of
variances by Bartlett’s test. Data on cadmium transport were
log transformed before statistical analysis. ANOVA was used
to investigate the effects of cadmium on the dependent
variables (cadmium uptake and transport, MRP activity,
DMT1, DMT1-IRE, FPN1, MRP1, MRP2, P-gp, and MT1
gene expressions), followed by Tukey’s test to determine
differences between means. The level of significance was set
at 𝑃 ≤ 0.05, two-sided.
3. Results
3.1. Assessment of Monolayer Integrity and Histology of
the Immature Caco-2 Cells. The passive diffusion of 14C-
mannitol across the monolayers was linear during the 3 h
experimental period. The apparent permeability coefficient
(𝑃app) for mannitol across the control monolayers was 1.15 ±
0.3 × 10
−6 cm/s (mean ± SD; 𝑛 = 3), demonstrating that the 7
days postconfluent cells had developed a barrier. Cadmium
pretreatment did not influence the apparent permeability
for mannitol (𝑃 = 0.60). The TEER across the control
monolayers was 275 ± 18Ω∗cm2 (mean ± SEM; 𝑛 = 6).
Background resistance across filters in control and cadmium
supplemented media (pH 7.4, 37∘C) without cells was about
80Ω∗cm2. Cadmium pretreatment did not affect the TEER
value for the monolayers (𝑃 = 0.70).
The histological examination of the sectioned immature
Caco-2 monolayers did not reveal any difference between
controls and cadmium pretreated cells. Dome formations
were observed in all monolayers at the end of the 7 days
differentiation period. The nuclei of the immature cells
appeared larger and more centrally located as compared to
mature cells, which have smaller nuclei with a more basal
localization [31].
3.2. Transepithelial Transport and Uptake of 109Cd. The
transport of cadmium from the apical to the basolateral
chamber across the Caco-2 monolayers was linear after an
initial one-hour lag phase (Figure 1(a)). At each 30min time
interval, the transport of cadmium was higher across the
cadmium pretreated monolayers as compared to the controls
(Figure 1(a)). The cumulative cadmium transport from the
apical to the basolateral chamber was increased by 170%
in cells pretreated with cadmium (Figure 1(b)). Intracellular
cadmium levels in cadmium pretreated cells was reduced by
approximately 20% as compared to the controls at the end of
the 3 h incubation period (Figure 1(c)).
3.3. Gene Expressions. The MRP1 gene expression in cells
pretreated with cadmium was increased by 55% (Figure 2),
whereas the MRP2 and P-gp mRNA levels were not signifi-
cantly affected by cadmium pretreatment. The gene expres-
sions of the iron transporters DMT1, DMT1-IRE, and FPN1
were not affected in theCaco-2 cells pretreatedwith cadmium
(Figure 2). Gene expression of MT1 was increased 30 times
after cadmium pretreatment (control: 1.0 ± 0.1; cadmium:
31.5 ± 2.1; mean ± SEM; 𝑛 = 3; 𝑃 ≤ 0.001).
3.4. Functional Activity: MRP-Mediated Efflux of Calcein.
The basolateral efflux of calcein fluorescent dye was mea-
sured during two hours after one hour initial loading of
the nonfluorescent dye calcein AM. Cadmium pretreatment
significantly increased the efflux of calcein into the basolat-
eral chamber (Figure 3(a)). The efflux of calcein into apical
chamber was approximately four times higher than the efflux
into the basolateral chamber. However, the pretreatment with
cadmium did not affect the calcein efflux into the apical
chamber (Figure 3(b)).
4. Discussion
The role of transporters in the high gastrointestinal uptake of
cadmium in newborns is not fully understood [2, 17]. In addi-
tion, the cellular mechanism behind the increased intestinal
absorption of cadmium following continuous exposure than
after a single dose of the metal remains to be elucidated [25].
In the present study, we have demonstrated an upregulation
of the basolateral efflux protein MRP1 in immature Caco-2
cells after cadmium pretreatment, both at the gene and at the
functional level. The increased MRP1 gene expression and
activity was correlated to an increased cadmium transport
across the basolateral membrane, indicating that MRP1 is
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Figure 1: Fraction of 109Cd transported across immature Caco-2 cells from the apical to the basolateral chamber (a). Cumulative transport
of 109Cd across immature Caco-2 cells (b). Apical uptake of 109Cd across into immature Caco-2 cells (c). Data are presented as mean ± SEM;
𝑛 = 6; statistical significant difference compared to control; ∗𝑃 ≤ 0.05, ∗∗∗𝑃 ≤ 0.001. Legends to the pretreatments: C: control; Cd: cadmium.
involved in this process. The augmented transport of the
metal was not due to disrupted tight junctions as neither
the passive diffusion of the paracellular marker mannitol nor
the TEER was affected by cadmium. Cadmium is known
to bind with high affinity to the thiol (SH) groups in GSH
[28, 46], and it has been demonstrated in yeast that cadmium-
GSH complexes can be transported by the MRP1 analogue
YCF1 [21, 22]. Cadmium-GSH has also been shown to be
transported by MRP1 in lung epithelial fibroblasts [47]. We
suggest that cadmium, bound to GSH, is transported by
MRP1 across the basolateral membrane in the immature
intestinal cells, a transport that is upregulated by cadmium
pretreatment.
Our results showed a 30-fold increase in intracellu-
lar level of MT mRNA after cadmium pretreatment of
the immature Caco-2 cells. Previously, a 5-fold increase
in MT has been reported after long-term cadmium treat-
ment of mature Caco-2 cells [26], indicating that imma-
ture cells are more sensitive to cadmium treatment and
therefore induces MT expression more strongly. In con-
cordance, Cardin et al. [35], demonstrated a higher induc-
tion of MT in immature Caco-2 cells compared to mature
ones. These authors also reported that cadmium treatment
decreased the thiol content by 65% in Caco-2 cells differ-
entiated for 7 days, while no effects were observed on thiol
content in mature Caco-2 cells, indicating developmental
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Figure 2: Relative gene expressions of MRP1, MRP2, P-gp, DMT1, DMT1-IRE, and FPN1 in immature Caco-2 cells. Data are expressed
relative to controls, set at 1; mean ± SEM; 𝑛 = 3; statistical significant difference compared to control; ∗𝑃 ≤ 0.05, ∗∗𝑃 ≤ 0.01. Legends to the
pretreatments: C: control; Cd: cadmium.
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Figure 3: Relative basolateral (a) and apical (b) efflux of fluorescent calcein in immature Caco-2 cells. The MRP1 activity was examined by
determining the cumulative level of fluorescent calcein effluxed into the basolateral chamber following two hours of incubation. Data are
expressed relative to controls, set at 1; mean ± SD; 𝑛 = 6; statistical significant difference compared to control; ∗∗𝑃 ≤ 0.01. Legends to the
pretreatments: C: control; Cd: cadmium.
differences in the cell defense against cadmium-induced
toxicity [35]. The reduced thiol content is in line with our
suggestion of cadmium-induced formation of cadmium-
GSH complexes, which are transported out of the cells by
MRP1.
Several studies have demonstrated that the iron trans-
porters DMT1 and FPN1, upregulated at iron deficiency
and repressed at iron sufficient conditions, are involved in
cadmium transport in adult mammals [15, 16]. It has been
suggested that there are ontogenic changes in the intestinal
absorption and handling of iron in neonates and that iron
absorption and expressions of DMT1 and FPN1 are not
regulated until the time of weaning [18, 48]. Both iron
transporters are exclusively located intracellularly at mid
infancy and not until weaning present at the membranes of
the duodenal enterocytes in rats [49, 50] and in pigs [17].
In suckling piglets, neither iron nor cadmium pretreatments
have resulted in any effect on expression or localization of
duodenal DMT1 or FPN1 [17]. In the present study, cadmium
pretreatment did not affect the gene expression of DMT1
or FPN1 in the Caco-2 cells. Thus, the increased apical to
basolateral cadmium transport in cadmium pretreated cells
ISRN Toxicology 7
cannot be explained by an increased expression of these iron
transporters.
Our results demonstrate that reduced apical uptake of
cadmium into cadmiumpretreated Caco-2 cells does not cor-
relate to a reducedDMT1 or DMT1-IRE gene expression.This
indicates that cadmiummay be taken up by some other, non-
DMT1-mediated, mechanism across the apical membrane
of immature enterocytes and that cadmium pretreatment
negatively affects this process. The reduced cadmium uptake
after cadmium pretreatment may also in part be explained
by the slightly increased gene expression of the apical efflux
protein P-gp. It has been reported that long-term cadmium
exposure increases P-gp expression and activity in mature
Caco-2 cells [23]. In the present study, cadmiumpretreatment
did not affect gene expression or function of MRP2, which
otherwise could have explained the reduced intracellular
cadmium levels following exposure to the element on the
apical side. The reduced cadmium uptake in the cadmium-
treated immature cells did not correlate to the transport of
the element into the basolateral chamber. However, it should
be pointed out that the amount of cadmium transported
across the basolateral membrane of the cells only constitutes
a minor fraction of the total cellular uptake. Thus, even if the
intracellular cadmium levels are lower in cadmiumpretreated
Caco-2 monolayers, the amount of metal, for example, MRP1
is still sufficient to saturate the transporter for extracellular
efflux out of the cell into the basolateral compartment.
Despite the strong MT induction, in vivo studies have
demonstrated that MT only plays minimal roles in the gas-
trointestinal absorption of cadmium, though the retention of
the metal in other tissues is MT dependent [27]. Accordingly,
uptake of cadmium in the immature Caco-2 cells pretreated
with cadmium was significantly reduced, indicating that MT
is not involved in the retention of cadmium in neonatal
enterocytes.
In summary, our results showed that cadmium pretreat-
ment of immature Caco-2 cells upregulated MRP1 both at
the gene expression and functional levels, which correlated
to an increased transport of the metal across the basolateral
membrane. In addition, the two iron transporters DMT1 and
FPN1 were not affected by cadmium and appeared not to be
involved in the intestinal transport of cadmium in immature
Caco-2 cells. In conclusion, our data indicate that continuous
cadmium exposure increases the absorption of the metal
in immature intestinal cells and that MRP1 conceivably is
involved in the intestinal cadmium absorption in neonates.
Conflict of Interests
There is no conflict of interests.
Acknowledgments
The authors wish to thank Ph.D. Lucia Lazarova for valuable
support regarding cell culture. This study was supported by
the Swedish Research Council for Environment, Agricultural
Sciences and Spatial Planning (FORMAS).
References
[1] H. M. Crews, L. M. Owen, N. Langford et al., “Use of the
stable isotope 106Cd for studying dietary cadmium absorption
in humans,” Toxicology Letters, vol. 112-113, pp. 201–207, 2000.
[2] G. Eklund, K. Petersson Grawe´, and A. Oskarsson, “Bioavail-
ability of cadmium from infant diets in newborn rats,” Archives
of Toxicology, vol. 75, no. 9, pp. 522–530, 2001.
[3] G. Eklund and A. Oskarsson, “Exposure of cadmium from
infant formulas and weaning foods,” Food Additives and Con-
taminants, vol. 16, no. 12, pp. 509–519, 1999.
[4] K. P. Grawe´, J. Pickova, P. C. Dutta, and A. Oskarsson, “Fatty
acid alterations in liver and milk of cadmium exposed rats and
in brain of their suckling offspring,” Toxicology Letters, vol. 148,
no. 1-2, pp. 73–82, 2004.
[5] A. A˚kesson, M. Berglund, A. Schu¨tz, P. Bjellerup, K. Bremme,
andM. Vahter, “Cadmium exposure in pregnancy and lactation
in relation to iron status,”American Journal of Public Health, vol.
92, no. 2, pp. 284–287, 2002.
[6] M. Berglund, A. A˚kesson, B. Nermell, andM.Vahter, “Intestinal
absorption of dietary cadmium inwomendepends on body iron
stores and fiber intake,” Environmental Health Perspectives, vol.
102, no. 12, pp. 1058–1066, 1994.
[7] E. Ba´ra´ny, I. A. Bergdahl, L. E. Bratteby et al., “Iron status
influences trace element levels in human blood and serum,”
Environmental Research, vol. 98, no. 2, pp. 215–223, 2005.
[8] P. R. Flanagan, J. S. McLellan, J. Haist, G. Cherian, M. J.
Chamberlain, and L. S. Valberg, “Increased dietary cadmium
absorption in mice and human subjects with iron deficiency,”
Gastroenterology, vol. 74, no. 5 I, pp. 841–846, 1978.
[9] I. M. Olsson, I. Bensryd, T. Lundh, H. Ottosson, S. Skerfving,
and A. Oskarsson, “Cadmium in blood and urine—impact of
sex, age, dietary intake, iron status, and former smoking—
association of renal effects,” Environmental Health Perspectives,
vol. 110, no. 12, pp. 1185–1190, 2002.
[10] F. Canonne-Hergaux, S. Gruenheid, P. Ponka, and P. Gros,
“Cellular and subcellular localization of the Nramp2 iron
transporter in the intestinal brush border and regulation by
dietary iron,” Blood, vol. 93, no. 12, pp. 4406–4417, 1999.
[11] A. T. McKie, P. Marciani, A. Rolfs et al., “A novel duodenal
iron-regulated transporter, IREG1, implicated in the basolateral
transfer of iron to the circulation,” Molecular Cell, vol. 5, no. 2,
pp. 299–309, 2000.
[12] N. C. Andrews and P. J. Schmidt, “Iron homeostasis,” Annual
Review of Physiology, vol. 69, pp. 69–85, 2007.
[13] H. Zoller, R. O. Koch, I. Theurl et al., “Expression of the
duodenal iron transporters divalent-metal transporter 1 and
ferroportin 1 in iron deficiency and iron overload,” Gastroen-
terology, vol. 120, no. 6, pp. 1412–1419, 2001.
[14] J. E. Nelson, V. R. Mugford, E. Kilcourse, R. S. Wang, and K. V.
Kowdley, “Relationship between gene expression of duodenal
iron transporters and iron stores in hemochromatosis subjects,”
American Journal of Physiology, vol. 298, no. 1, pp. G57–G62,
2010.
[15] D. W. Kim, K. Y. Kim, B. S. Choi et al., “Regulation of metal
transporters by dietary iron, and the relationship between body
iron levels and cadmium uptake,” Archives of Toxicology, vol. 81,
no. 5, pp. 327–334, 2007.
[16] D. Y. Ryu, S. J. Lee, D. W. Park, B. S. Choi, C. D. Klaassen, and J.
D. Park, “Dietary iron regulates intestinal cadmium absorption
through iron transporters in rats,” Toxicology Letters, vol. 152,
no. 1, pp. 19–25, 2004.
8 ISRN Toxicology
[17] H. O¨hrvik,A.Oskarsson, T. Lundh, S. Skerfving, and J. Tallkvist,
“Impact of iron status on cadmium uptake in suckling piglets,”
Toxicology, vol. 240, no. 1-2, pp. 15–24, 2007.
[18] W. I. Leong, C. L. Bowlus, J. Tallkvist, and B. Lo¨nnerdal, “DMT1
and FPN1 expression during infancy: developmental regulation
of iron absorption,”American Journal of Physiology, vol. 285, no.
6, pp. G1153–G1161, 2003.
[19] F. The´venod, “Catch me if you can! novel aspects of cadmium
transport inmammalian cells,”BioMetals, vol. 23, no. 5, pp. 857–
875, 2010.
[20] R. Beedholm-Ebsen, K. van de Wetering, T. Hardlei, E. Nexø,
P. Borst, and S. K. Moestrup, “Identification of multidrug
resistance protein 1 (MRP1/ABCC1) as a molecular gate for
cellular export of cobalamin,” Blood, vol. 115, no. 8, pp. 1632–
1639, 2010.
[21] Z. S. Li, Y. P. Lu, R. G. Zhen, M. Szczypka, D. J. Thiele, and
P. A. Rea, “A new pathway for vacuolar cadmium seques-
tration in Saccharomyces cerevisiae: YCF1-catalyzed transport
of bis(glutathionato)cadmium,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 94, no.
1, pp. 42–47, 1997.
[22] R. Tommasini, R. Evers, E. Vogt et al., “The human multidrug
resistance-associated protein functionally complements the
yeast cadmium resistance factor,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 93, no.
13, pp. 6743–6748, 1996.
[23] C. Huynh-Delerme, H. Huet, L. Noe¨l, A. Frigieri, and M. Kolf-
Clauw, “Increased functional expression of P-glycoprotein in
Caco-2 TC7 cells exposed long-term to cadmium,” Toxicology
In Vitro, vol. 19, no. 4, pp. 439–447, 2005.
[24] S. A. Terlouw, C. Graeff, P. H. E. Smeets et al., “Short and
long term influences of heavy metals on anionic drug efflux
from renal proximal tubule,” Journal of Pharmacology and
Experimental Therapeutics, vol. 301, no. 2, pp. 578–585, 2002.
[25] K. H. Flaig, K. Schu¨mann, and B. Elsenhans, “Jejunal transfer
rates of 109cadmium chloride increase in rats in vitro and in
vivo after oral pretreatment with cadmium or zinc chloride,”
Toxicology, vol. 183, no. 1–3, pp. 199–209, 2003.
[26] A. Blais, S. Lecoeur, G. Milhaud, D. Tome´, and M. Kolf-Clauw,
“Cadmium uptake and transepithelial transport in control and
long-term exposed Caco-2 cells: the role of metallothionein,”
Toxicology and Applied Pharmacology, vol. 160, no. 1, pp. 76–85,
1999.
[27] C. D. Klaassen, J. Liu, and B. A. Diwan, “Metallothionein
protection of cadmium toxicity,” Toxicology and Applied Phar-
macology, vol. 238, no. 3, pp. 215–220, 2009.
[28] C. D. Klaassen, J. Liu, and S. Choudhuri, “Metallothionein:
an intracellular protein to protect against cadmium toxicity,”
Annual Review of Pharmacology andToxicology, vol. 39, pp. 267–
294, 1999.
[29] P. Artursson, K. Palm, and K. Luthman, “Caco-2 monolayers
in experimental and theoretical predictions of drug transport,”
Advanced Drug Delivery Reviews, vol. 46, no. 1–3, pp. 27–43,
2001.
[30] P. Artursson, “Epithelial transport of drugs in cell culture. I: a
model for studying the passive diffusion of drugs over intestinal
absorptive (Caco-2) cells,” Journal of Pharmaceutical Sciences,
vol. 79, no. 6, pp. 476–482, 1990.
[31] I. Chantret, A. Barbat, E. Dussaulx, M. G. Brattain, and A.
Zweibaum, “Epithelial polarity, villin expression, and entero-
cytic differentiation of cultured human colon carcinoma cells:
a survey of twenty cell lines,” Cancer Research, vol. 48, no. 7, pp.
1936–1942, 1988.
[32] M. Pinto, S. Robine Leon, and M. D. Appay, “Enterocyte-like
differentiation and polarization of the human colon carcinoma
cell line Caco-2 in culture,” Biology of the Cell, vol. 47, no. 3, pp.
323–330, 1983.
[33] D. I. Bannon, R. Abounader, P. S. J. Lees, and J. P. Bressler, “Effect
of DMT1 knockdown on iron, cadmium, and lead uptake in
Caco-2 cells,”American Journal of Physiology, vol. 284, no. 1, pp.
C44–C50, 2003.
[34] M. Boveri, P. Pazos, A. Gennari, J. Casado, T. Hartung, and P.
Prieto, “Comparison of the sensitivity of different toxicological
endpoints in Caco-2 cells after cadmium chloride treatment,”
Archives of Toxicology, vol. 78, no. 4, pp. 201–206, 2004.
[35] G. B. Cardin, M. Mantha, and C. Jumarie, “Resistance to
cadmium as a function of Caco-2 cell differentiation: role of
reactive oxygen species in cadmium- but not zinc-induced
adaptation mechanisms,” BioMetals, vol. 22, no. 5, pp. 753–769,
2009.
[36] C. Jumarie, P. G. C. Campbell, A. Berteloot, M. Houde, and F.
Denizeau, “Caco-2 cell line used as an in vitro model to study
cadmium accumulation in intestinal epithelial cells,” Journal of
Membrane Biology, vol. 158, no. 1, pp. 31–48, 1997.
[37] J. Tallkvist, C. L. Bowlus, and B. Lo¨nnerdal, “DMT1 gene
expression and cadmium absorption in human absorptive
enterocytes,” Toxicology Letters, vol. 122, no. 2, pp. 171–177, 2001.
[38] P. Carrie`re, M.Mantha, S. Champagne-Paradis, and C. Jumarie,
“Characterization of basolateral to apical transepithelial trans-
port of cadmium in intestinal TC7 cell monolayers,” BioMetals,
vol. 24, no. 5, pp. 857–874, 2011.
[39] G. Englund, F. Rorsman, A. Ro¨nnblom et al., “Regional levels
of drug transporters along the human intestinal tract: co-
expression of ABC and SLC transporters and comparison with
Caco-2 cells,” European Journal of Pharmaceutical Sciences, vol.
29, no. 3-4, pp. 269–277, 2006.
[40] H. M. Prime-Chapman, R. A. Fearn, A. E. Cooper, V. Moore,
and B. H. Hirst, “Differential multidrug resistance-associated
protein 1 through 6 isoform expression and function in human
intestinal epithelial Caco-2 cells,” Journal of Pharmacology and
Experimental Therapeutics, vol. 311, no. 2, pp. 476–484, 2004.
[41] J. Tallkvist and H. Tja¨lve, “Transport of nickel across monolay-
ers of human intestinal Caco-2 cells,” Toxicology and Applied
Pharmacology, vol. 151, no. 1, pp. 117–122, 1998.
[42] I. Hubatsch, E. G. E. Ragnarsson, and P. Artursson, “Determi-
nation of drug permeability and prediction of drug absorption
in Caco-2 monolayers,” Nature Protocols, vol. 2, no. 9, pp. 2111–
2119, 2007.
[43] K. J. Livak and T. D. Schmittgen, “Analysis of relative gene
expression data using real-time quantitative PCR and the 2-
ΔΔCT method,”Methods, vol. 25, no. 4, pp. 402–408, 2001.
[44] L. Homolya, Z. Hollo, U. A. Germann, I. Pastan, M. M.
Gottesman, and B. Sarkadi, “Fluorescent cellular indicators are
extruded by the multidrug resistance protein,” The Journal of
Biological Chemistry, vol. 268, no. 29, pp. 21493–21496, 1993.
[45] N. Feller, H. J. Broxterman, D. C. R. Wahrer, and H. M. Pinedo,
“ATP-dependent efflux of calcein by the multidrug resistance
protein (MRP): no inhibition by intracellular glutathione deple-
tion,” FEBS Letters, vol. 368, no. 2, pp. 385–388, 1995.
[46] M. S. Dı´az-Cruz, J. Mendieta, R. Tauler, and M. Esteban,
“Cadmium-binding properties of glutathione: a chemometrical
analysis of voltammetric data,” Journal of Inorganic Biochem-
istry, vol. 66, no. 1, pp. 29–36, 1997.
ISRN Toxicology 9
[47] S. H. Oh, S. Y. Lee, C. H. Choi, S. H. Lee, and S. C. Lim,
“Cadmium adaptation is regulated by multidrug resistance-
associated protein-mediated Akt pathway and metallothionein
induction,” Archives of Pharmacal Research, vol. 32, no. 6, pp.
883–891, 2009.
[48] M. Domello¨f, R. J. Cohen, K. G. Dewey, O. Hernell, L. L.
Rivera, and B. Lo¨nnerdal, “Iron supplementation of breast-fed
Honduran and Swedish infants from 4 to 9 months of age,”
Journal of Pediatrics, vol. 138, no. 5, pp. 679–687, 2001.
[49] S. L. Kelleher and B. Lo¨nnerdal, “Zinc supplementation reduces
iron absorption through age-dependent changes in small intes-
tine iron transporter expression in suckling rat pups,” Journal of
Nutrition, vol. 136, no. 5, pp. 1185–1191, 2006.
[50] V. Lopez, Y. A. Suzuki, and B. Lo¨nnerdal, “Ontogenic changes
in lactoferrin receptor and DMT1 in mouse small intestine:
implications for iron absorption during early life,” Biochemistry
and Cell Biology, vol. 84, no. 3, pp. 337–344, 2006.
Submit your manuscripts at
http://www.hindawi.com
BioMed Research 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2013
The Scientific 
World Journal
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Journal of
Toxicology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
ISRN 
Pain
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Journal of
Drug Delivery
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Medicinal Chemistry
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Advances in 
Pharmacological 
Sciences
ISRN 
Toxicology
Volume 2013
Hindawi Publishing Corporation
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Emergency Medicine 
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Anesthesiology Research
and Practice
Volume 2013
ISRN 
Medicinal 
Chemistry
Hindawi Publishing Corporation
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com
Volume 2013
Toxins
Journal of
ISRN 
Pharmaceutics
Volume 2013
Hindawi Publishing Corporation
http://www.hindawi.com
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Mediators
inflaMMation
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
 Autoimmune 
Diseases
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Journal of
Pharmaceutics
Scientifica
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
ISRN 
Pharmacology
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2013
Antibiotics
Journal of
